We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Chromatin Plasticity Characterizes the Embryonic Stem Cell Nucleus

By LabMedica International staff writers
Posted on 02 Aug 2012
A recent paper presented new insights into the mechanisms that control chromatin plasticity in human embryonic stem cells and that allow these cells to differentiate in to many different types of tissue.

Investigators at the Hebrew University of Jerusalem (Israel) employed molecular, microscopic, and genomic approaches to compare the nature of chromatin (DNA, RNA, and protein) in embryonic stem cells (ESCs) to that found in mature, differentiated cells.

They reported in the June 19, 2012, issue of the journal Nature Communications that the use of epigenetic drugs and mutant ESCs lacking various chromatin proteins revealed that histone acetylation, G9a-mediated histone H3 lysine 9 (H3K9) methylation, and lamin A expression, all affected chromatin protein dynamics. More...


Histone acetylation controlled, almost exclusively, euchromatin protein dynamics. Euchromatin comprises the most active portion of the genome within the cell nucleus. It is a lightly packed form of chromatin that is rich in gene concentration, and is often under active transcription.

Lamin A expression regulates heterochromatin protein dynamics. Heterochromatin is tightly coiled chromosomal material that stains deeply during interphase and is believed to be genetically inactive. In differentiated cells, lamin A binds compacted domains of chromatin and anchors them to the cell’s nuclear envelope. Lamin A was not found in ESCs, which seems to generate a more dynamic chromatin state in the ESC nucleus.

G9a, the histone-lysine N-methyltransferase also known as H3 lysine-9 specific 3, regulates both euchromatin and heterochromatin protein dynamics.

In contrast, the investigators found that DNA methylation and nucleosome repeat length had little or no effect on chromatin-binding protein dynamics in ESCs. Altered chromatin dynamics associated with perturbed ESC differentiation.

“If we can apply this new understanding about the mechanisms that give embryonic stem cells their plasticity, then we can increase or decrease the dynamics of the proteins that bind DNA and thereby increase or decrease the cells’ differentiation potential,” said senior author Dr. Eran Meshorer, professor of genetics at the Hebrew University of Jerusalem. “This could expedite the use of embryonic stem cells in cell therapy and regenerative medicine, by enabling the creation of cells in the laboratory which could be implanted in humans to cure diseases characterized by cell death, such as Alzheimer's, Parkinson's, diabetes, and other degenerative diseases.”

Related Links:

Hebrew University of Jerusalem




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.